IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANGELA ESCOBAR

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1760012835
CMS profile
10515137
Location
LONGVIEW, WA

General Payments · PY2021–2024

$5,734.06

  • Reported across 315 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,170.56

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family WA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,170.56 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $250.47 11
Regeneron Healthcare Solutions, Inc. $149.15 7
GENZYME CORPORATION $146.32 6
Takeda Pharmaceuticals U.S.A., Inc. $134.59 7
CSL Behring $77.82 3
TerSera Therapeutics LLC $65.58 2
Pharming Healthcare, Inc. $62.70 3
Amgen Inc. $50.86 2
Blueprint Medicines Corporation $46.48 2
NOVARTIS PHARMACEUTICALS CORPORATION $43.50 2
Grifols USA, LLC $43.06 2
Octapharma USA, Inc. $26.99 1
Genentech USA, Inc. $23.38 1
X4 Pharmaceuticals, Inc. $21.93 1
GlaxoSmithKline, LLC. $13.92 1
Mylan Specialty L.P. $13.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,600.93 108
PY2022 $1,707.98 96
PY2023 $1,254.59 59
PY2024 $1,170.56 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.23 01/30/2024 Food and Beverage Undisputed 01/23/2026 1115605686 CMS
Amgen Inc. $28.63 05/20/2024 Food and Beverage Undisputed 01/23/2026 1115605693 CMS
AstraZeneca Pharmaceuticals LP $17.85 01/23/2024 Food and Beverage Undisputed 01/23/2026 1104294262 CMS
AstraZeneca Pharmaceuticals LP $35.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 1104455736 CMS
AstraZeneca Pharmaceuticals LP $19.56 04/01/2024 Food and Beverage Undisputed 01/23/2026 1104405891 CMS
AstraZeneca Pharmaceuticals LP $22.19 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105571919 CMS
AstraZeneca Pharmaceuticals LP $21.08 06/20/2024 Food and Beverage Undisputed 01/23/2026 1105901072 CMS
AstraZeneca Pharmaceuticals LP $20.47 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105393308 CMS
AstraZeneca Pharmaceuticals LP $24.78 09/11/2024 Food and Beverage Undisputed 01/23/2026 1105510038 CMS
AstraZeneca Pharmaceuticals LP $21.64 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105481465 CMS
AstraZeneca Pharmaceuticals LP $20.71 10/28/2024 Food and Beverage Undisputed 01/23/2026 1105785926 CMS
AstraZeneca Pharmaceuticals LP $25.85 11/14/2024 Food and Beverage Undisputed 01/23/2026 1105458163 CMS
AstraZeneca Pharmaceuticals LP $21.34 11/20/2024 Food and Beverage Undisputed 01/23/2026 1105299604 CMS
Blueprint Medicines Corporation $24.56 01/10/2024 Food and Beverage Undisputed 01/23/2026 1147455707 CMS
Blueprint Medicines Corporation $21.92 06/05/2024 Food and Beverage Undisputed 01/23/2026 1147455791 CMS
CSL Behring $21.33 03/14/2024 Food and Beverage Undisputed 01/23/2026 1134632771 CMS
CSL Behring $23.33 04/26/2024 Food and Beverage Undisputed 01/23/2026 1134632783 CMS
CSL Behring $33.16 09/13/2024 Food and Beverage Undisputed 01/23/2026 1134632813 CMS
Genentech USA, Inc. $23.38 04/09/2024 Food and Beverage Undisputed 01/23/2026 1133142088 CMS
GENZYME CORPORATION $25.22 04/17/2024 Food and Beverage Undisputed 01/23/2026 1139994265 CMS
GENZYME CORPORATION $38.41 06/18/2024 Food and Beverage Undisputed 01/23/2026 1139994267 CMS
GENZYME CORPORATION $22.51 07/31/2024 Food and Beverage Undisputed 01/23/2026 1139994273 CMS
GENZYME CORPORATION $19.17 08/20/2024 Food and Beverage Undisputed 01/23/2026 1139994275 CMS
GENZYME CORPORATION $17.46 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139994279 CMS
GENZYME CORPORATION $23.55 11/11/2024 Food and Beverage Undisputed 01/23/2026 1139994339 CMS
GlaxoSmithKline, LLC. $13.92 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116487431 CMS
Grifols USA, LLC $20.89 05/23/2024 Food and Beverage Undisputed 01/23/2026 1124712236 CMS
Grifols USA, LLC $22.17 08/07/2024 Food and Beverage Undisputed 01/23/2026 1124712234 CMS
Mylan Specialty L.P. $13.81 03/20/2024 Food and Beverage Undisputed 01/23/2026 1147335298 CMS
Novartis Pharmaceuticals Corporation $21.76 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086821729 CMS
Novartis Pharmaceuticals Corporation $21.74 06/13/2024 Food and Beverage Undisputed 01/23/2026 1086821735 CMS
Octapharma USA, Inc. $26.99 08/14/2024 Food and Beverage Undisputed 01/23/2026 1142321796 CMS
Pharming Healthcare, Inc. $21.19 04/22/2024 Food and Beverage Undisputed 01/23/2026 1132175646 CMS
Pharming Healthcare, Inc. $20.02 10/21/2024 Food and Beverage Undisputed 01/23/2026 1132175653 CMS
Pharming Healthcare, Inc. $21.49 12/13/2024 Food and Beverage Undisputed 01/23/2026 1132175660 CMS
Regeneron Healthcare Solutions, Inc. $13.17 01/19/2024 Food and Beverage Undisputed 01/23/2026 1114298250 CMS
Regeneron Healthcare Solutions, Inc. $18.29 02/06/2024 Food and Beverage Undisputed 01/23/2026 1114298252 CMS
Regeneron Healthcare Solutions, Inc. $20.84 03/05/2024 Food and Beverage Undisputed 01/23/2026 1114298254 CMS
Regeneron Healthcare Solutions, Inc. $27.29 06/11/2024 Food and Beverage Undisputed 01/23/2026 1114298256 CMS
Regeneron Healthcare Solutions, Inc. $21.08 09/25/2024 Food and Beverage Undisputed 01/23/2026 1114298258 CMS
Regeneron Healthcare Solutions, Inc. $23.70 10/09/2024 Food and Beverage Undisputed 01/23/2026 1114298260 CMS
Regeneron Healthcare Solutions, Inc. $24.78 11/06/2024 Food and Beverage Undisputed 01/23/2026 1114298262 CMS
Takeda Pharmaceuticals U.S.A., Inc. $11.47 02/07/2024 Food and Beverage Undisputed 01/23/2026 1137739992 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.56 04/10/2024 Food and Beverage Undisputed 01/23/2026 1137739994 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.24 04/10/2024 Food and Beverage Undisputed 01/23/2026 1137739996 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.03 08/19/2024 Food and Beverage Undisputed 01/23/2026 1137739998 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.39 09/24/2024 Food and Beverage Undisputed 01/23/2026 1137740000 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.95 10/03/2024 Food and Beverage Undisputed 01/23/2026 1137740002 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.95 10/31/2024 Food and Beverage Undisputed 01/23/2026 1137740004 CMS
TerSera Therapeutics LLC $29.07 04/05/2024 Food and Beverage Undisputed 01/23/2026 1144719831 CMS
TerSera Therapeutics LLC $36.51 05/14/2024 Food and Beverage Undisputed 01/23/2026 1144719833 CMS
X4 Pharmaceuticals, Inc. $21.93 12/16/2024 Food and Beverage Undisputed 01/23/2026 1147391106 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.